IntelliPharmaCeutics International (IPCIQ) Financial Statements
IntelliPharmaCeutics International Financial Overview
IntelliPharmaCeutics International's market cap is currently $2.38M. The company's EPS TTM is ―; its P/E ratio is ―; IntelliPharmaCeutics International has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Nov 22 | Nov 21 | Nov 20 | Nov 19 | Nov 18 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ― | ― | ― | ― | ― |
| Gross Profit | $ 65.73K | ― | $ 1.40M | $ 3.45M | $ 1.59M |
| Operating Income | $ -2.85M | $ -4.17M | $ -4.68M | $ -7.83M | $ -13.33M |
| EBITDA | $ -2.39M | $ -4.45M | $ -1.97M | $ -7.34M | $ -12.88M |
| Net Income | $ -2.89M | $ -5.15M | $ -3.39M | $ -8.08M | $ -13.75M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ― | ― | ― | ― | ― |
| Total Assets | $ 1.16M | $ 2.10M | $ 3.39M | $ 3.80M | $ 11.47M |
| Total Debt | $ 2.33M | $ 1.92M | $ 2.11M | $ 1.90M | $ 1.79M |
| Net Debt | $ 2.24M | $ 1.15M | $ 1.91M | $ 1.84M | $ -4.85M |
| Total Liabilities | $ 12.01M | $ 10.25M | $ 9.70M | $ 7.49M | $ 7.37M |
| Stockholders' Equity | ― | ― | ― | ― | ― |
| Cash Flow | |||||
| Free Cash Flow | $ -888.22K | $ -2.46M | ― | $ -6.66M | $ -12.51M |
| Operating Cash Flow | ― | ― | ― | ― | ― |
| Investing Cash Flow | ― | ― | ― | ― | ― |
| Financing Cash Flow | ― | ― | ― | ― | ― |
Currency in USD